Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 10 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

137 Age-associated characteristics of the tumor microenvironment in patients with advanced basal cell carcinoma treated with anti-PD-1 therapy

6 more authors
9 affiliations
  1. 1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
  2. 2Aff230 grid.21107.350000000121719311Department of Surgery, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg-Kimmel Institute for Cancer Immunotherapy Baltimore MD USA
  3. 31 Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  4. 4Oncology, Johns Hopkins University, Baltimore, Maryland, USA
  5. 5Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
  6. 6Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
  7. 7Johns Hopkins University School of Medicine, Baltimore, MD, USA
  8. 8Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA
  9. 9Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Related

  1. A macrophage-associated immunosuppressive subtype defined by Lactobacillus/Bifidobacterium-associated host genes characterizes prognosis and the immune microenvironment in hepatocellular carcinoma.
    Qimeng Chang, Huarong Mao, Jinfeng Feng +4
    Frontiers in cellular and infection microbiologyPeer-reviewedCC BYFull textImmunologyEurope PMCPMC
  2. Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
    Emilien Billon, Cécile Dalban, Stephane Oudard +17
    European Urology OncologyPeer-reviewedLicence not stated6 citedGeneral biologyHAL
  3. Characteristics and outcomes of ICU patients with bacterial catheter-associated urinary tract infection
    Mateusz Bartoszewicz, Marta Krysik, Sławomir Lech Czaban +1
    PLOS OnePeer-reviewedCC BY 4.0Full textSystems & synthetic biologyEpidemiology & public healthPLOS
  4. Cancer Cell CD73 Loss Promotes a Dual Inflammatory and Immunosuppressive Microenvironment in Endometrial Carcinoma
    Hannah N. Lee, Xingyuan Zhang, Suzanne M. Crumley +6
    Cancer Research CommunicationsPeer-reviewedCC BY 4.0Full textImmunologyPMC
  5. Interleukin-33 alleviates the immunosuppressive tumor microenvironment and enhances anti-programmed death ligand-1 immunotherapy efficacy in hepatocellular carcinoma
    Ensi Ma, Yange Gu, Weiqiao He +6
    Chinese Medical JournalPeer-reviewedCC BY-NC-ND 4.0Full textImmunologyPMC
BibTeX
@article{wang2026ageassociated,
  title = {{137 Age-associated characteristics of the tumor microenvironment in patients with advanced basal cell carcinoma treated with anti-PD-1 therapy}},
  author = {Hao Wang and Tracee McMiller and Vrinda Madan and Govind Warrier and Elizabeth Will and Julie S Deutsch and Janis M Taube and Marissa Mojena and Isaac R Morales and Marnie Wang and Kara M Schenk and Megan D Schollenberger and William H Sharfman and Alice Pons and Daniel J Lewis and Alan E Berger and Suzanne L Topalian and Evan J Lipson},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0137},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0137},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 137 Age-associated characteristics of the tumor microenvironment in patients with advanced basal cell carcinoma treated with anti-PD-1 therapy
AU  - Hao Wang
AU  - Tracee McMiller
AU  - Vrinda Madan
AU  - Govind Warrier
AU  - Elizabeth Will
AU  - Julie S Deutsch
AU  - Janis M Taube
AU  - Marissa Mojena
AU  - Isaac R Morales
AU  - Marnie Wang
AU  - Kara M Schenk
AU  - Megan D Schollenberger
AU  - William H Sharfman
AU  - Alice Pons
AU  - Daniel J Lewis
AU  - Alan E Berger
AU  - Suzanne L Topalian
AU  - Evan J Lipson
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0137
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0137
SN  - 2051-1426
ER  -